Aurora Cannabis (ACB) Competitors C$6.11 -0.31 (-4.83%) (As of 05:28 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades ACB vs. CRON, THCX, GUD, WEED, CPH, FIRE, EPI, OGI, ICC, and RIVShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Cronos Group (CRON), Hydropothecary (THCX), Knight Therapeutics (GUD), Canopy Growth (WEED), Cipher Pharmaceuticals (CPH), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Organigram (OGI), ICC Labs (ICC), and RIV Capital (RIV). These companies are all part of the "drug manufacturers - specialty & generic" industry. Aurora Cannabis vs. Cronos Group Hydropothecary Knight Therapeutics Canopy Growth Cipher Pharmaceuticals Supreme Cannabis ESSA Pharma Organigram ICC Labs RIV Capital Cronos Group (TSE:CRON) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, community ranking, media sentiment, valuation and risk. Which has more risk and volatility, CRON or ACB? Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 2.71, suggesting that its stock price is 171% more volatile than the S&P 500. Does the MarketBeat Community prefer CRON or ACB? Aurora Cannabis received 461 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 63.10% of users gave Aurora Cannabis an outperform vote while only 50.74% of users gave Cronos Group an outperform vote. CompanyUnderperformOutperformCronos GroupOutperform Votes6950.74% Underperform Votes6749.26% Aurora CannabisOutperform Votes53063.10% Underperform Votes31036.90% Which has higher valuation and earnings, CRON or ACB? Aurora Cannabis has higher revenue and earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos GroupC$101.78M10.22-C$57.37M-C$0.21-12.95Aurora CannabisC$278.98M1.20-C$30.32M-C$0.63-9.70 Do analysts rate CRON or ACB? Cronos Group presently has a consensus price target of C$3.18, indicating a potential upside of 16.91%. Aurora Cannabis has a consensus price target of C$5.85, indicating a potential downside of 4.26%. Given Cronos Group's higher possible upside, equities research analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Aurora Cannabis 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.60 Is CRON or ACB more profitable? Aurora Cannabis has a net margin of -11.53% compared to Cronos Group's net margin of -56.43%. Cronos Group's return on equity of -5.29% beat Aurora Cannabis' return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-56.43% -5.29% -3.73% Aurora Cannabis -11.53%-6.13%-1.87% Does the media favor CRON or ACB? In the previous week, Aurora Cannabis had 6 more articles in the media than Cronos Group. MarketBeat recorded 7 mentions for Aurora Cannabis and 1 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.32 beat Aurora Cannabis' score of 0.48 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals have more ownership in CRON or ACB? 16.0% of Cronos Group shares are held by institutional investors. Comparatively, 13.4% of Aurora Cannabis shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryAurora Cannabis beats Cronos Group on 12 of the 19 factors compared between the two stocks. Ad Porter & CompanyMusk threatens Liberal’s fake “energy crisis”Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$333.97MC$1.10BC$5.04BC$5.61BDividend YieldN/A3.13%4.81%5.75%P/E Ratio-9.70105.06133.4227.82Price / Sales1.202,087.151,120.441,253.90Price / Cash1.259.8240.6379.10Price / Book0.593.174.753.31Net Income-C$30.32MC$142.32MC$118.34MC$287.14M7 Day Performance-0.97%-2.10%11.87%-4.01%1 Month Performance3.21%-2.51%11.93%0.33%1 Year Performance869.84%99.14%31.39%35.94% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.4015 of 5 starsC$6.11-4.8%C$5.85-4.3%+903.1%C$333.97MC$278.98M-9.701,073Analyst ForecastNews CoverageCRONCronos Group1.3265 of 5 starsC$2.76+1.1%C$3.18+15.2%+6.9%C$1.06BC$101.78M-13.00450Positive NewsTHCXHydropothecaryN/AC$5.30+6.6%N/A+0.0%C$949.11MN/A0.00N/AHigh Trading VolumeGUDKnight Therapeutics2.2279 of 5 starsC$5.15-1.0%C$7.08+37.5%+1.0%C$521.23MC$337.87M-25.80725WEEDCanopy Growth1.2143 of 5 starsC$4.37-1.1%C$7.12+62.9%+534.8%C$370.84MC$287.10M-0.562,700Analyst DowngradeNews CoverageCPHCipher Pharmaceuticals0.5946 of 5 starsC$14.17-0.5%C$12.50-11.8%+128.3%C$362.61MC$22.16M11.395FIRESupreme CannabisN/AC$0.34+3.0%N/AN/AC$259.40MC$53.29M-10.81400EPIESSA PharmaN/AC$8.20+7.2%N/A+0.0%C$237.87MN/A-8.2725OGIOrganigram3.2013 of 5 starsC$2.19+4.3%C$3.86+76.4%+26.7%C$237.77MC$149.21M-0.84987Analyst ForecastGap UpICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/AGap UpRIVRIV CapitalN/AC$1.50-6.3%N/AN/AC$213.65MC$11.33M-1.6312News Coverage Related Companies and Tools Related Companies CRON Alternatives THCX Alternatives GUD Alternatives WEED Alternatives CPH Alternatives FIRE Alternatives EPI Alternatives OGI Alternatives ICC Alternatives RIV Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:ACB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
